Public Policy Letters, Statements, Legal Briefs, & Other Responses
← Back to all Letters & Statements
-
ACMG Comments on CMS Proposed Rule for Changes to CLIA Personnel Requirements
-
ACMG Comments on FDA Draft Guidance for Products Incorporating Genome Editing
-
ACMG Response to Opposing Inclusion of the VALID Act in the FDASLA Act
-
ACMG Letter to Michigan Medicaid on Coverage of Prenatal & Carrier Screening
-
ACMG Letter to Indiana Medicaid Supporting Coverage of Prenatal Screening and Testing
-
ACMG Response to RFI on NIH Genomic Data Sharing Policy
-
ACMG Letter of Support for the Right Drug Dose Now Act
-
ACMG Responds to CMS Proposed Rule for CY 2022 PFS and Other Policy Changes (NCD 180.2)
-
ACMG Calls on Courts to Stop Texas Abortion Law
-
ACMG Comments on Cures 2.0 Discussion Draft